ID   OTC_HUMAN               Reviewed;         354 AA.
AC   P00480; A8K9P2; D3DWB0; Q3KNR1; Q6B0I1; Q9NYJ5;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 3.
DT   10-MAY-2017, entry version 206.
DE   RecName: Full=Ornithine carbamoyltransferase, mitochondrial;
DE            EC=2.1.3.3;
DE   AltName: Full=Ornithine transcarbamylase;
DE            Short=OTCase;
DE   Flags: Precursor;
GN   Name=OTC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS PRO-111 AND ARG-270.
RC   TISSUE=Liver;
RX   PubMed=6372096; DOI=10.1126/science.6372096;
RA   Horwich A.L., Fenton W.A., Williams K.R., Kalousek F., Kraus J.P.,
RA   Doolittle R.F., Konigsberg W., Rosenberg L.E.;
RT   "Structure and expression of a complementary DNA for the nuclear coded
RT   precursor of human mitochondrial ornithine transcarbamylase.";
RL   Science 224:1068-1074(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LEU-101.
RC   TISSUE=Liver;
RX   PubMed=2836378;
RA   Hata A., Tsuzuki T., Shimada K., Takiguchi M., Mori M., Matsuda I.;
RT   "Structure of the human ornithine transcarbamylase gene.";
RL   J. Biochem. 103:302-308(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-46.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-36.
RX   PubMed=3895227; DOI=10.1073/pnas.82.15.4930;
RA   Horwich A.L., Kalousek F., Rosenberg L.E.;
RT   "Arginine in the leader peptide is required for both import and
RT   proteolytic cleavage of a mitochondrial precursor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:4930-4933(1985).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-26.
RX   PubMed=3782067; DOI=10.1093/oxfordjournals.jbchem.a121764;
RA   Hata A., Tsuzuki T., Shimada K., Takiguchi M., Mori M., Matsuda I.;
RT   "Isolation and characterization of the human ornithine
RT   transcarbamylase gene: structure of the 5'-end region.";
RL   J. Biochem. 100:717-725(1986).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 269-289, AND VARIANT OTCD
RP   GLN-277.
RX   PubMed=8081373; DOI=10.1093/hmg/3.5.831;
RA   Gilbert-Dussardier B., Rabier D., Strautnieks S., Segues B.,
RA   Bonnefont J.-P., Munnich A.;
RT   "A novel arginine (245) to glutamine change in exon 8 of the ornithine
RT   carbamoyl transferase gene in two unrelated children presenting with
RT   late onset deficiency and showing the same enzymatic pattern.";
RL   Hum. Mol. Genet. 3:831-832(1994).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   CHARACTERIZATION OF VARIANTS OTCD ARG-195; VAL-196 AND ALA-264.
RX   PubMed=8112735; DOI=10.1007/BF00210596;
RA   Matsuura T., Hoshide R., Setoyama C., Komaki S., Kiwaki K., Endo F.,
RA   Nishikawa S., Matsuda I.;
RT   "Expression of four mutant human ornithine transcarbamylase genes in
RT   cultured Cos 1 cells relates to clinical phenotypes.";
RL   Hum. Genet. 93:129-134(1994).
RN   [12]
RP   ACETYLATION AT LYS-88, AND ENZYME REGULATION.
RX   PubMed=19318352; DOI=10.1074/jbc.M901921200;
RA   Yu W., Lin Y., Yao J., Huang W., Lei Q., Xiong Y., Zhao S., Guan K.L.;
RT   "Lysine 88 acetylation negatively regulates ornithine
RT   carbamoyltransferase activity in response to nutrient signals.";
RL   J. Biol. Chem. 284:13669-13675(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOG.
RX   PubMed=9852088; DOI=10.1074/jbc.273.51.34247;
RA   Shi D., Morizono H., Ha Y., Aoyagi M., Tuchman M., Allewell N.M.;
RT   "1.85-A resolution crystal structure of human ornithine
RT   transcarbamoylase complexed with N-phosphonacetyl-L-ornithine.
RT   Catalytic mechanism and correlation with inherited deficiency.";
RL   J. Biol. Chem. 273:34247-34254(1998).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH SUBSTRATE.
RX   PubMed=10813810;
RX   DOI=10.1002/(SICI)1097-0134(20000601)39:4<271::AID-PROT10>3.0.CO;2-E;
RA   Shi D., Morizono H., Aoyagi M., Tuchman M., Allewell N.M.;
RT   "Crystal structure of human ornithine transcarbamylase complexed with
RT   carbamoyl phosphate and L-norvaline at 1.9 A resolution.";
RL   Proteins 39:271-277(2000).
RN   [15]
RP   REVIEW ON VARIANTS.
RX   PubMed=8364586; DOI=10.1002/humu.1380020304;
RA   Tuchman M.;
RT   "Mutations and polymorphisms in the human ornithine transcarbamylase
RT   gene.";
RL   Hum. Mutat. 2:174-178(1993).
RN   [16]
RP   REVIEW ON VARIANTS.
RX   PubMed=7627182; DOI=10.1002/humu.1380050404;
RA   Tuchman M., Plante R.J.;
RT   "Mutations and polymorphisms in the human ornithine transcarbamylase
RT   gene: mutation update addendum.";
RL   Hum. Mutat. 5:293-295(1995).
RN   [17]
RP   REVIEW ON VARIANTS, AND 3D-STRUCTURE MODELING.
RX   PubMed=8544185; DOI=10.1136/jmg.32.9.680;
RA   Tuchman M., Morizono H., Reish O., Yuan X., Allewell N.M.;
RT   "The molecular basis of ornithine transcarbamylase deficiency:
RT   modelling the human enzyme and the effects of mutations.";
RL   J. Med. Genet. 32:680-688(1995).
RN   [18]
RP   VARIANT OTCD GLN-141.
RX   PubMed=3170748; DOI=10.1172/JCI113738;
RA   Maddalena A., Spence J.E., O'Brien W.E., Nussbaum R.L.;
RT   "Characterization of point mutations in the same arginine codon in
RT   three unrelated patients with ornithine transcarbamylase deficiency.";
RL   J. Clin. Invest. 82:1353-1358(1988).
RN   [19]
RP   VARIANT OTCD GLN-141, AND CHARACTERIZATION OF VARIANT OTCD GLN-141.
RX   PubMed=2556444; DOI=10.1172/JCI114360;
RA   Lee J.T., Nussbaum R.L.;
RT   "An arginine to glutamine mutation in residue 109 of human ornithine
RT   transcarbamylase completely abolishes enzymatic activity in Cos1
RT   cells.";
RL   J. Clin. Invest. 84:1762-1766(1989).
RN   [20]
RP   VARIANTS OTCD GLN-26; PRO-45 AND GLU-216, AND VARIANT ARG-46.
RX   PubMed=2474822; DOI=10.1073/pnas.86.15.5888;
RA   Grompe M., Muzny D.M., Caskey C.T.;
RT   "Scanning detection of mutations in human ornithine transcarbamoylase
RT   by chemical mismatch cleavage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:5888-5892(1989).
RN   [21]
RP   VARIANT OTCD TRP-277.
RX   PubMed=2347583; DOI=10.1016/0888-7543(90)90537-5;
RA   Finkelstein J.E., Francomano C.A., Brusilow S.W., Traystman M.D.;
RT   "Use of denaturing gradient gel electrophoresis for detection of
RT   mutation and prospective diagnosis in late onset ornithine
RT   transcarbamylase deficiency.";
RL   Genomics 7:167-172(1990).
RN   [22]
RP   VARIANTS OTCD GLN-92 AND LEU-320, AND VARIANT PRO-111.
RX   PubMed=1671317;
RA   Grompe M., Caskey C.T., Fenwick R.G. Jr.;
RT   "Improved molecular diagnostics for ornithine transcarbamylase
RT   deficiency.";
RL   Am. J. Hum. Genet. 48:212-222(1991).
RN   [23]
RP   VARIANT OTCD LEU-225.
RX   PubMed=1721894; DOI=10.1007/BF00206063;
RA   Hentzen D., Pelet A., Feldman D., Rabier D., Berthelot J., Munnich A.;
RT   "Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site
RT   of the ornithine transcarbamylase gene.";
RL   Hum. Genet. 88:153-156(1991).
RN   [24]
RP   VARIANTS OTCD GLU-79; THR-94; PHE-304 AND ASP-345.
RX   PubMed=1480464; DOI=10.1203/00006450-199211000-00020;
RA   Tuchman M., Holzknecht R.A., Gueron A.B., Berry S.A., Tsai M.Y.;
RT   "Six new mutations in the ornithine transcarbamylase gene detected by
RT   single-strand conformational polymorphism.";
RL   Pediatr. Res. 32:600-604(1992).
RN   [25]
RP   VARIANT OTCD PRO-140.
RX   PubMed=8099056; DOI=10.1007/BF00217350;
RA   Tsai M.Y., Holzknecht R.A., Tuchman M.;
RT   "Single-strand conformational polymorphism and direct sequencing
RT   applied to carrier testing in families with ornithine transcarbamylase
RT   deficiency.";
RL   Hum. Genet. 91:321-325(1993).
RN   [26]
RP   VARIANTS OTCD LEU-117; LEU-182 AND CYS-203.
RX   PubMed=8019569; DOI=10.1002/humu.1380030325;
RA   Tuchman M., Plante R.J., Giguere Y., Lemieux B.;
RT   "The ornithine transcarbamylase gene: new 'private' mutations in four
RT   patients and study of a polymorphism.";
RL   Hum. Mutat. 3:318-320(1994).
RN   [27]
RP   VARIANTS OTCD GLY-126; HIS-129 AND MET-172.
RX   PubMed=8081398; DOI=10.1002/humu.1380030415;
RA   Matsuura T., Hoshide R., Kiwaki K., Komaki S., Koike E., Endo F.,
RA   Oyanagi K., Suzuki Y., Kato I., Ishikawa K., Yoda H., Kamitani S.,
RA   Sakaki Y., Matsuda I.;
RT   "Four newly identified ornithine transcarbamylase (OTC) mutations
RT   (D126G, R129H, I172M and W332X) in Japanese male patients with early-
RT   onset OTC deficiency.";
RL   Hum. Mutat. 3:402-406(1994).
RN   [28]
RP   VARIANTS OTCD HIS-40; HIS-129; ARG-195; THR-225; GLN-277 AND GLU-309
RP   DEL.
RX   PubMed=7951259; DOI=10.1002/humu.1380040109;
RA   Tuchman M., Plante R.J., McCann M.T., Qureshi A.A.;
RT   "Seven new mutations in the human ornithine transcarbamylase gene.";
RL   Hum. Mutat. 4:57-60(1994).
RN   [29]
RP   VARIANTS OTCD THR-159 AND VAL-209.
RX   PubMed=8530002; DOI=10.1007/BF00197410;
RA   Garcia-Perez M.A., Sanjurjo P., Briones P., Garcia-Munoz M.J.,
RA   Rubio V.;
RT   "A splicing mutation, a nonsense mutation (Y167X) and two missense
RT   mutations (I159T and A209V) in Spanish patients with ornithine
RT   transcarbamylase deficiency.";
RL   Hum. Genet. 96:549-551(1995).
RN   [30]
RP   VARIANT OTCD GLU-269.
RX   PubMed=7474905; DOI=10.1007/BF00710430;
RA   Zimmer K.P., Matsuura T., Colombo J.-P., Koch H.G., Ullrich K.,
RA   Deufel T., Harms E., Matsuda I.;
RT   "A novel point mutation at codon 269 of the ornithine transcarbamylase
RT   (OTC) gene causing neonatal onset of OTC deficiency.";
RL   J. Inherit. Metab. Dis. 18:356-357(1995).
RN   [31]
RP   VARIANTS OTCD MET-125; ARG-188; VAL-209 AND LEU-302.
RX   PubMed=8807340;
RX   DOI=10.1002/(SICI)1098-1004(1996)8:1<74::AID-HUMU11>3.3.CO;2-6;
RA   Gilbert-Dussardier B., Segues B., Rozet J.-M., Rabier D., Calvas P.,
RA   de Lumley L., Bonnefont J.-P., Munnich A.;
RT   "Partial duplication [dup. TCAC (178)] and novel point mutations
RT   (T125M, G188R, A209V, and H302L) of the ornithine transcarbamylase
RT   gene in congenital hyperammonemia.";
RL   Hum. Mutat. 8:74-76(1996).
RN   [32]
RP   VARIANTS OTCD HIS-40; ASN-88; TYR-202 AND ASN-263.
RA   Guardamagna O., Gatti E., Parini R., Plante R.J., Tuchman M.;
RT   "Genotype-phenotype correlations in ornithine transcarbamylase
RT   deficiency.";
RL   Enzyme Protein 49:191-191(1996).
RN   [33]
RP   VARIANTS OTCD ASN-88; CYS-176; ALA-220; TYR-302 AND LYS-343.
RX   PubMed=8956038;
RX   DOI=10.1002/(SICI)1098-1004(1996)8:4<333::AID-HUMU6>3.0.CO;2-8;
RA   Leibundgut E.O., Wermuth B., Colombo J.-P., Liechti-Gallati S.;
RT   "Ornithine transcarbamylase deficiency: characterization of gene
RT   mutations and polymorphisms.";
RL   Hum. Mutat. 8:333-339(1996).
RN   [34]
RP   VARIANT OTCD GLU-272 DEL.
RX   PubMed=8956045;
RX   DOI=10.1002/(SICI)1098-1004(1996)8:4<373::AID-HUMU13>3.0.CO;2-#;
RA   Segues B., Saugier Veber P., Rabier D., Calvas P., Saudubray J.-M.,
RA   Gilbert-Dussardier B., Bonnefont J.-P., Munnich A.;
RT   "A 3-base pair in-frame deletion in exon 8 (delGlu272/273) of the
RT   ornithine transcarbamylase gene in late-onset hyperammonemic coma.";
RL   Hum. Mutat. 8:373-374(1996).
RN   [35]
RP   VARIANTS OTCD ILE-44; GLN-141 AND TYR-214, AND VARIANT LEU-101.
RX   PubMed=8830175; DOI=10.1007/BF01799346;
RA   Yoo H.-W., Kim G.-H., Lee D.-H.;
RT   "Identification of new mutations in the ornithine transcarbamylase
RT   (OTC) gene in Korean families.";
RL   J. Inherit. Metab. Dis. 19:31-42(1996).
RN   [36]
RP   VARIANTS OTCD.
RX   PubMed=9286441;
RX   DOI=10.1002/(SICI)1096-8628(19970905)71:4<378::AID-AJMG2>3.3.CO;2-9;
RA   Matsuda I., Tanase S.;
RT   "The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese
RT   families with OTC deficiency.";
RL   Am. J. Med. Genet. 71:378-383(1997).
RN   [37]
RP   CHARACTERIZATION OF VARIANT OTCD TRP-277.
RX   PubMed=9065786; DOI=10.1042/bj3220625;
RA   Morizono H., Tuchman M., Rajagopal B.S., McCann M.T., Listrom C.D.,
RA   Yuan X., Venugopal D., Barany G., Allewell N.M.;
RT   "Expression, purification and kinetic characterization of wild-type
RT   human ornithine transcarbamylase and a recurrent mutant that produces
RT   'late onset' hyperammonaemia.";
RL   Biochem. J. 322:625-631(1997).
RN   [38]
RP   VARIANTS OTCD PRO-63; ASP-100; ASP-183; LYS-213 AND PRO-340, AND
RP   VARIANT PHE-43.
RX   PubMed=9143919;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:5<409::AID-HUMU5>3.3.CO;2-P;
RA   Oppliger Leibundgut E., Liechti-Gallati S., Colombo J.-P., Wermuth B.;
RT   "Ornithine transcarbamylase deficiency: ten new mutations and high
RT   proportion of de novo mutations in heterozygous females.";
RL   Hum. Mutat. 9:409-411(1997).
RN   [39]
RP   VARIANTS OTCD.
RX   PubMed=9266388; DOI=10.1023/A:1005301513465;
RA   Tuchman M., Morizono H., Rajagopal B.S., Plante R.J., Allewell N.M.;
RT   "Identification of 'private' mutations in patients with ornithine
RT   transcarbamylase deficiency.";
RL   J. Inherit. Metab. Dis. 20:525-527(1997).
RN   [40]
RP   VARIANTS OTCD 178-THE-LEU-179 DEL; HIS-180; PRO-201; ARG-207; ILE-264
RP   AND ARG-267.
RX   PubMed=9452024;
RA   Shimadzu M., Matsumoto H., Matsuura T., Kobayashi K., Komaki S.,
RA   Kiwaki K., Hoshide R., Endo F., Saheki T., Matsuda I.;
RT   "Ten novel mutations of the ornithine transcarbamylase (OTC) gene in
RT   OTC deficiency.";
RL   Hum. Mutat. Suppl. 1:S5-S7(1998).
RN   [41]
RP   VARIANTS OTCD CYS-39; GLN-244 AND ARG-303.
RX   PubMed=9452049;
RA   Calvas P., Seques B., Rozet J.-M., Rabier D., Bonnefont J.-P.,
RA   Munnich A.;
RT   "Novel intragenic deletions and point mutations of the ornithine
RT   transcarbamylase gene in congenital hyperammonemia.";
RL   Hum. Mutat. Suppl. 1:S81-S84(1998).
RN   [42]
RP   VARIANT OTCD ASP-55.
RX   PubMed=9452065;
RA   Nishiyori A., Yoshino M., Tananari Y., Matsuura T., Hoshide R.,
RA   Matsuda I., Mori M., Kato H.;
RT   "Y55D mutation in ornithine transcarbamylase associated with late-
RT   onset hyperammonemia in a male.";
RL   Hum. Mutat. Suppl. 1:S131-S133(1998).
RN   [43]
RP   VARIANT OTCD ASP-83.
RA   Bartholomew D.W., McClellan J.;
RT   "A novel missense mutation in the human ornithine transcarbamylase
RT   gene.";
RL   Hum. Mutat. 12:220-220(1998).
RN   [44]
RP   VARIANTS OTCD PHE-172; VAL-188 AND ARG-197.
RX   PubMed=10502831;
RX   DOI=10.1002/(SICI)1098-1004(199910)14:4<352::AID-HUMU15>3.3.CO;2-4;
RA   Climent C., Garcia-Perez M.A., Sanjurjo P., Ruiz-Sanz J.-I.,
RA   Vilaseca M.A., Pineda M., Campistol J., Rubio V.;
RT   "Identification of a cytogenetic deletion and of four novel mutations
RT   (Q69X, I172F, G188V, G197R) affecting the gene for ornithine
RT   transcarbamylase (OTC) in Spanish patients with OTC deficiency.";
RL   Hum. Mutat. 14:352-353(1999).
RN   [45]
RP   VARIANTS OTCD LYS-198; VAL-209 AND LYS-326, AND VARIANT ARG-270.
RX   PubMed=10070627; DOI=10.1023/A:1005476021549;
RA   Popowska E., Ciara E., Rokicki D., Pronicka E.;
RT   "Three novel and one recurrent ornithine carbamoyltransferase gene
RT   mutations in Polish patients.";
RL   J. Inherit. Metab. Dis. 22:92-93(1999).
RN   [46]
RP   VARIANTS OTCD LYS-262; ALA-264 AND LEU-265.
RX   PubMed=10737985;
RX   DOI=10.1002/(SICI)1098-1004(200004)15:4<380::AID-HUMU12>3.0.CO;2-Q;
RA   Giorgi M., Morrone A., Donati M.A., Ciani F., Bardelli T.,
RA   Biasucci G., Zammarchi E.;
RT   "Lymphocyte mRNA analysis of the ornithine transcarbamylase gene in
RT   Italian OTCD male patients and manifesting carriers: identification of
RT   novel mutations.";
RL   Hum. Mutat. 15:380-381(2000).
RN   [47]
RP   VARIANTS OTCD SER-160; PHE-191; ILE-206; PHE-301; HIS-305 AND PRO-341,
RP   AND VARIANT ALA-333.
RX   PubMed=11793483; DOI=10.1002/humu.9011;
RA   Climent C., Rubio V.;
RT   "Identification of seven novel missense mutations, two splice-site
RT   mutations, two microdeletions and a polymorphic amino acid
RT   substitution in the gene for ornithine transcarbamylase (OTC) in
RT   patients with OTC deficiency.";
RL   Hum. Mutat. 19:185-186(2002).
RN   [48]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-270.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- CATALYTIC ACTIVITY: Carbamoyl phosphate + L-ornithine = phosphate
CC       + L-citrulline.
CC   -!- ENZYME REGULATION: Negatively regulated by lysine acetylation.
CC       {ECO:0000269|PubMed:19318352}.
CC   -!- PATHWAY: Nitrogen metabolism; urea cycle; L-citrulline from L-
CC       ornithine and carbamoyl phosphate: step 1/1.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:10813810,
CC       ECO:0000269|PubMed:9852088}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in liver and intestinal
CC       mucosa.
CC   -!- PTM: Acetylation at Lys-88 negatively regulates ornithine
CC       carbamoyltransferase activity in response to nutrient signals.
CC       {ECO:0000269|PubMed:19318352}.
CC   -!- DISEASE: Ornithine carbamoyltransferase deficiency (OTCD)
CC       [MIM:311250]: An X-linked disorder of the urea cycle which causes
CC       a form of hyperammonemia. Mutations with no residual enzyme
CC       activity are always expressed in hemizygote males by a very severe
CC       neonatal hyperammonemic coma that generally proves to be fatal.
CC       Heterozygous females are either asymptomatic or express orotic
CC       aciduria spontaneously or after protein intake. The disorder is
CC       treatable with supplemental dietary arginine and low protein diet.
CC       The arbitrary classification of patients into the 'neonatal' group
CC       (clinical hyperammonemia in the first few days of life) and 'late'
CC       onset (clinical presentation after the neonatal period) has been
CC       used to differentiate severe from mild forms.
CC       {ECO:0000269|PubMed:10070627, ECO:0000269|PubMed:10502831,
CC       ECO:0000269|PubMed:10737985, ECO:0000269|PubMed:11793483,
CC       ECO:0000269|PubMed:1480464, ECO:0000269|PubMed:1671317,
CC       ECO:0000269|PubMed:1721894, ECO:0000269|PubMed:2347583,
CC       ECO:0000269|PubMed:2474822, ECO:0000269|PubMed:2556444,
CC       ECO:0000269|PubMed:3170748, ECO:0000269|PubMed:7474905,
CC       ECO:0000269|PubMed:7951259, ECO:0000269|PubMed:8019569,
CC       ECO:0000269|PubMed:8081373, ECO:0000269|PubMed:8081398,
CC       ECO:0000269|PubMed:8099056, ECO:0000269|PubMed:8112735,
CC       ECO:0000269|PubMed:8530002, ECO:0000269|PubMed:8807340,
CC       ECO:0000269|PubMed:8830175, ECO:0000269|PubMed:8956038,
CC       ECO:0000269|PubMed:8956045, ECO:0000269|PubMed:9065786,
CC       ECO:0000269|PubMed:9143919, ECO:0000269|PubMed:9266388,
CC       ECO:0000269|PubMed:9286441, ECO:0000269|PubMed:9452024,
CC       ECO:0000269|PubMed:9452049, ECO:0000269|PubMed:9452065,
CC       ECO:0000269|Ref.32, ECO:0000269|Ref.43}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ATCase/OTCase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K02100; AAA59975.1; -; mRNA.
DR   EMBL; D00230; BAA00161.1; -; Genomic_DNA.
DR   EMBL; AK292757; BAF85446.1; -; mRNA.
DR   EMBL; AL607040; CAI95193.1; -; Genomic_DNA.
DR   EMBL; AF241726; CAI95193.1; JOINED; Genomic_DNA.
DR   EMBL; AL606748; CAI95193.1; JOINED; Genomic_DNA.
DR   EMBL; AL606748; CAI95408.1; -; Genomic_DNA.
DR   EMBL; AL607040; CAI95408.1; JOINED; Genomic_DNA.
DR   EMBL; AF241726; CAI95408.1; JOINED; Genomic_DNA.
DR   EMBL; CH471141; EAW59439.1; -; Genomic_DNA.
DR   EMBL; CH471141; EAW59440.1; -; Genomic_DNA.
DR   EMBL; BC074745; AAH74745.1; -; mRNA.
DR   EMBL; BC107153; AAI07154.1; -; mRNA.
DR   EMBL; BC107154; AAI07155.1; -; mRNA.
DR   EMBL; BC114496; AAI14497.1; -; mRNA.
DR   EMBL; M11235; AAA59976.1; -; Genomic_DNA.
DR   EMBL; D00095; BAA00058.1; -; Genomic_DNA.
DR   EMBL; X04443; CAA28039.1; -; Genomic_DNA.
DR   EMBL; S73640; AAB31859.1; -; Genomic_DNA.
DR   CCDS; CCDS14247.1; -.
DR   PIR; A41444; OWHU.
DR   RefSeq; NP_000522.3; NM_000531.5.
DR   UniGene; Hs.117050; -.
DR   PDB; 1C9Y; X-ray; 1.90 A; A=34-354.
DR   PDB; 1EP9; X-ray; 2.40 A; A=34-354.
DR   PDB; 1FVO; X-ray; 2.60 A; A/B=34-354.
DR   PDB; 1OTH; X-ray; 1.85 A; A=34-354.
DR   PDBsum; 1C9Y; -.
DR   PDBsum; 1EP9; -.
DR   PDBsum; 1FVO; -.
DR   PDBsum; 1OTH; -.
DR   ProteinModelPortal; P00480; -.
DR   SMR; P00480; -.
DR   BioGrid; 111050; 12.
DR   STRING; 9606.ENSP00000039007; -.
DR   BindingDB; P00480; -.
DR   ChEMBL; CHEMBL2222; -.
DR   DrugBank; DB03519; 2-Amino-Pentanoic Acid.
DR   DrugBank; DB00155; L-Citrulline.
DR   DrugBank; DB00129; L-Ornithine.
DR   DrugBank; DB02011; N-(Phosphonoacetyl)-L-Ornithine.
DR   DrugBank; DB04185; Norvaline.
DR   iPTMnet; P00480; -.
DR   PhosphoSitePlus; P00480; -.
DR   BioMuta; OTC; -.
DR   DMDM; 84028235; -.
DR   REPRODUCTION-2DPAGE; P00480; -.
DR   EPD; P00480; -.
DR   MaxQB; P00480; -.
DR   PaxDb; P00480; -.
DR   PeptideAtlas; P00480; -.
DR   PRIDE; P00480; -.
DR   Ensembl; ENST00000039007; ENSP00000039007; ENSG00000036473.
DR   GeneID; 5009; -.
DR   KEGG; hsa:5009; -.
DR   UCSC; uc004def.5; human.
DR   CTD; 5009; -.
DR   DisGeNET; 5009; -.
DR   GeneCards; OTC; -.
DR   GeneReviews; OTC; -.
DR   HGNC; HGNC:8512; OTC.
DR   HPA; HPA000243; -.
DR   HPA; HPA000570; -.
DR   MalaCards; OTC; -.
DR   MIM; 300461; gene.
DR   MIM; 311250; phenotype.
DR   neXtProt; NX_P00480; -.
DR   OpenTargets; ENSG00000036473; -.
DR   Orphanet; 664; Ornithine transcarbamylase deficiency.
DR   PharmGKB; PA32840; -.
DR   eggNOG; KOG1504; Eukaryota.
DR   eggNOG; COG0078; LUCA.
DR   GeneTree; ENSGT00510000047417; -.
DR   HOGENOM; HOG000022686; -.
DR   HOVERGEN; HBG007881; -.
DR   InParanoid; P00480; -.
DR   KO; K00611; -.
DR   OMA; EHPCQIL; -.
DR   OrthoDB; EOG091G0QB1; -.
DR   PhylomeDB; P00480; -.
DR   TreeFam; TF352580; -.
DR   BioCyc; MetaCyc:HS00516-MONOMER; -.
DR   BRENDA; 2.1.3.3; 2681.
DR   Reactome; R-HSA-70635; Urea cycle.
DR   SABIO-RK; P00480; -.
DR   UniPathway; UPA00158; UER00271.
DR   EvolutionaryTrace; P00480; -.
DR   GeneWiki; Ornithine_transcarbamylase; -.
DR   GenomeRNAi; 5009; -.
DR   PMAP-CutDB; P00480; -.
DR   PRO; PR:P00480; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000036473; -.
DR   CleanEx; HS_OTC; -.
DR   Genevisible; P00480; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:BHF-UCL.
DR   GO; GO:0016597; F:amino acid binding; IEA:Ensembl.
DR   GO; GO:0004585; F:ornithine carbamoyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0042301; F:phosphate ion binding; IEA:Ensembl.
DR   GO; GO:0005543; F:phospholipid binding; IEA:Ensembl.
DR   GO; GO:0097272; P:ammonia homeostasis; IMP:BHF-UCL.
DR   GO; GO:0055081; P:anion homeostasis; IEA:Ensembl.
DR   GO; GO:0006526; P:arginine biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0019240; P:citrulline biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0007494; P:midgut development; IEA:Ensembl.
DR   GO; GO:0006593; P:ornithine catabolic process; IDA:BHF-UCL.
DR   GO; GO:0070207; P:protein homotrimerization; IEA:Ensembl.
DR   GO; GO:0070781; P:response to biotin; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0010043; P:response to zinc ion; IEA:Ensembl.
DR   GO; GO:0000050; P:urea cycle; IDA:BHF-UCL.
DR   Gene3D; 3.40.50.1370; -; 2.
DR   InterPro; IPR006132; Asp/Orn_carbamoyltranf_P-bd.
DR   InterPro; IPR006130; Asp/Orn_carbamoylTrfase.
DR   InterPro; IPR006131; Asp_carbamoyltransf_Asp/Orn-bd.
DR   InterPro; IPR002292; Orn/put_carbamltrans.
DR   Pfam; PF00185; OTCace; 1.
DR   Pfam; PF02729; OTCace_N; 1.
DR   PRINTS; PR00100; AOTCASE.
DR   PRINTS; PR00102; OTCASE.
DR   SUPFAM; SSF53671; SSF53671; 1.
DR   TIGRFAMs; TIGR00658; orni_carb_tr; 1.
DR   PROSITE; PS00097; CARBAMOYLTRANSFERASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Amino-acid biosynthesis;
KW   Arginine biosynthesis; Complete proteome; Disease mutation;
KW   Mitochondrion; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Transit peptide; Urea cycle.
FT   TRANSIT       1     32       Mitochondrion.
FT   CHAIN        33    354       Ornithine carbamoyltransferase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000020334.
FT   REGION       90     94       Ornithine and carbamoyl phosphate
FT                                binding.
FT   REGION      168    171       Ornithine and carbamoyl phosphate
FT                                binding.
FT   REGION      263    267       Ornithine binding.
FT   REGION      302    305       Ornithine binding. {ECO:0000250}.
FT   ACT_SITE    303    303       {ECO:0000250}.
FT   BINDING     141    141       Carbamoyl phosphate.
FT   BINDING     141    141       Ornithine.
FT   BINDING     199    199       Ornithine.
FT   BINDING     330    330       Carbamoyl phosphate.
FT   BINDING     330    330       Ornithine.
FT   MOD_RES      70     70       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES      70     70       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES      80     80       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES      88     88       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:19318352}.
FT   MOD_RES      88     88       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     133    133       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     144    144       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     144    144       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     221    221       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     221    221       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     231    231       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     231    231       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     238    238       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     238    238       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     243    243       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     274    274       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     289    289       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     292    292       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     292    292       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     307    307       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   MOD_RES     307    307       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11725}.
FT   VARIANT      26     26       R -> Q (in OTCD; dbSNP:rs68031618).
FT                                {ECO:0000269|PubMed:2474822}.
FT                                /FTId=VAR_004843.
FT   VARIANT      39     39       G -> C (in OTCD; late onset;
FT                                dbSNP:rs72554306).
FT                                {ECO:0000269|PubMed:9452049}.
FT                                /FTId=VAR_004844.
FT   VARIANT      40     40       R -> C (in OTCD; late onset;
FT                                dbSNP:rs72554307).
FT                                /FTId=VAR_004845.
FT   VARIANT      40     40       R -> H (in OTCD; late onset;
FT                                dbSNP:rs72554308).
FT                                {ECO:0000269|PubMed:7951259,
FT                                ECO:0000269|Ref.32}.
FT                                /FTId=VAR_004846.
FT   VARIANT      43     43       L -> F (in dbSNP:rs72554309).
FT                                {ECO:0000269|PubMed:9143919}.
FT                                /FTId=VAR_004847.
FT   VARIANT      44     44       T -> I (in OTCD; dbSNP:rs72554310).
FT                                {ECO:0000269|PubMed:8830175}.
FT                                /FTId=VAR_004848.
FT   VARIANT      45     45       L -> P (in OTCD; dbSNP:rs72554312).
FT                                {ECO:0000269|PubMed:2474822}.
FT                                /FTId=VAR_004849.
FT   VARIANT      45     45       L -> V (in OTCD; dbSNP:rs72554311).
FT                                /FTId=VAR_004850.
FT   VARIANT      46     46       K -> R (in dbSNP:rs1800321).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2474822}.
FT                                /FTId=VAR_004851.
FT   VARIANT      47     47       N -> I (in OTCD; neonatal;
FT                                dbSNP:rs67939655).
FT                                /FTId=VAR_004852.
FT   VARIANT      50     50       G -> R (in OTCD; late onset;
FT                                dbSNP:rs67486158).
FT                                /FTId=VAR_004853.
FT   VARIANT      55     55       Y -> D (in OTCD; late onset;
FT                                dbSNP:rs72554319).
FT                                {ECO:0000269|PubMed:9452065}.
FT                                /FTId=VAR_004854.
FT   VARIANT      56     56       M -> T (in OTCD; late onset;
FT                                dbSNP:rs72554320).
FT                                /FTId=VAR_004855.
FT   VARIANT      60     60       S -> L (in OTCD; dbSNP:rs72554323).
FT                                /FTId=VAR_004856.
FT   VARIANT      63     63       L -> P (in OTCD; late onset;
FT                                dbSNP:rs72554324).
FT                                {ECO:0000269|PubMed:9143919}.
FT                                /FTId=VAR_004857.
FT   VARIANT      79     79       G -> E (in OTCD; dbSNP:rs72554331).
FT                                {ECO:0000269|PubMed:1480464}.
FT                                /FTId=VAR_004858.
FT   VARIANT      82     82       Missing (in OTCD).
FT                                /FTId=VAR_004859.
FT   VARIANT      83     83       G -> D (in OTCD; dbSNP:rs72554337).
FT                                {ECO:0000269|Ref.43}.
FT                                /FTId=VAR_004860.
FT   VARIANT      83     83       G -> R (in OTCD; neonatal;
FT                                dbSNP:rs72554336).
FT                                /FTId=VAR_004861.
FT   VARIANT      87     87       E -> K (in OTCD; dbSNP:rs72554338).
FT                                /FTId=VAR_004862.
FT   VARIANT      88     88       K -> N (in OTCD; late onset;
FT                                dbSNP:rs72554339).
FT                                {ECO:0000269|PubMed:8956038,
FT                                ECO:0000269|Ref.32}.
FT                                /FTId=VAR_004863.
FT   VARIANT      90     90       S -> R (in OTCD; dbSNP:rs72554342).
FT                                /FTId=VAR_004864.
FT   VARIANT      92     92       R -> Q (in OTCD; dbSNP:rs66550389).
FT                                {ECO:0000269|PubMed:1671317}.
FT                                /FTId=VAR_004865.
FT   VARIANT      93     93       T -> A (in OTCD; late onset;
FT                                dbSNP:rs72554344).
FT                                /FTId=VAR_004866.
FT   VARIANT      94     94       R -> T (in OTCD; dbSNP:rs72554345).
FT                                {ECO:0000269|PubMed:1480464}.
FT                                /FTId=VAR_004867.
FT   VARIANT     100    100       G -> D (in OTCD; late onset;
FT                                dbSNP:rs72554349).
FT                                {ECO:0000269|PubMed:9143919}.
FT                                /FTId=VAR_004868.
FT   VARIANT     101    101       F -> L (in dbSNP:rs1133135).
FT                                {ECO:0000269|PubMed:2836378,
FT                                ECO:0000269|PubMed:8830175}.
FT                                /FTId=VAR_004869.
FT   VARIANT     102    102       A -> E (in OTCD; dbSNP:rs72554350).
FT                                /FTId=VAR_004870.
FT   VARIANT     111    111       L -> P (in dbSNP:rs1800324).
FT                                {ECO:0000269|PubMed:1671317,
FT                                ECO:0000269|PubMed:6372096}.
FT                                /FTId=VAR_004871.
FT   VARIANT     117    117       H -> L (in OTCD; dbSNP:rs66539573).
FT                                {ECO:0000269|PubMed:8019569}.
FT                                /FTId=VAR_004872.
FT   VARIANT     117    117       H -> R (in OTCD; late onset;
FT                                dbSNP:rs66539573).
FT                                /FTId=VAR_004873.
FT   VARIANT     125    125       T -> M (in OTCD; neonatal;
FT                                dbSNP:rs72554356).
FT                                {ECO:0000269|PubMed:8807340}.
FT                                /FTId=VAR_004874.
FT   VARIANT     126    126       D -> G (in OTCD; 0.9% of wild-type
FT                                activity; early onset; dbSNP:rs72554358).
FT                                {ECO:0000269|PubMed:8081398}.
FT                                /FTId=VAR_004875.
FT   VARIANT     129    129       R -> H (in OTCD; 2.1% of wild-type
FT                                activity; early onset; dbSNP:rs66656800).
FT                                {ECO:0000269|PubMed:7951259,
FT                                ECO:0000269|PubMed:8081398}.
FT                                /FTId=VAR_004876.
FT   VARIANT     139    139       L -> S (in OTCD; dbSNP:rs72556259).
FT                                /FTId=VAR_004877.
FT   VARIANT     140    140       A -> P (in OTCD; late onset;
FT                                dbSNP:rs72556260).
FT                                {ECO:0000269|PubMed:8099056}.
FT                                /FTId=VAR_010605.
FT   VARIANT     141    141       R -> P (in OTCD; dbSNP:rs68026851).
FT                                /FTId=VAR_004878.
FT   VARIANT     141    141       R -> Q (in OTCD; activity is 100-fold
FT                                lower; most common point mutation;
FT                                dbSNP:rs68026851).
FT                                {ECO:0000269|PubMed:2556444,
FT                                ECO:0000269|PubMed:3170748,
FT                                ECO:0000269|PubMed:8830175}.
FT                                /FTId=VAR_004879.
FT   VARIANT     148    148       L -> F (in OTCD; dbSNP:rs66741318).
FT                                /FTId=VAR_004880.
FT   VARIANT     159    159       I -> T (in OTCD; dbSNP:rs72556269).
FT                                {ECO:0000269|PubMed:8530002}.
FT                                /FTId=VAR_004881.
FT   VARIANT     160    160       I -> S (in OTCD; dbSNP:rs67954347).
FT                                {ECO:0000269|PubMed:11793483}.
FT                                /FTId=VAR_012651.
FT   VARIANT     161    161       N -> S (in OTCD; dbSNP:rs72556271).
FT                                /FTId=VAR_004882.
FT   VARIANT     162    162       G -> R (in OTCD; dbSNP:rs66626662).
FT                                /FTId=VAR_004883.
FT   VARIANT     168    168       H -> Q (in OTCD; late onset;
FT                                dbSNP:rs72556276).
FT                                /FTId=VAR_004884.
FT   VARIANT     168    168       H -> R (in OTCD; late onset;
FT                                dbSNP:rs66867430).
FT                                /FTId=VAR_004885.
FT   VARIANT     172    172       I -> F (in OTCD; dbSNP:rs72556279).
FT                                {ECO:0000269|PubMed:10502831}.
FT                                /FTId=VAR_009233.
FT   VARIANT     172    172       I -> M (in OTCD; no activity; early
FT                                onset; dbSNP:rs72556280).
FT                                {ECO:0000269|PubMed:8081398}.
FT                                /FTId=VAR_004886.
FT   VARIANT     174    174       A -> P (in OTCD; dbSNP:rs72556281).
FT                                /FTId=VAR_004887.
FT   VARIANT     175    175       D -> V (in OTCD; dbSNP:rs68033093).
FT                                /FTId=VAR_004888.
FT   VARIANT     176    176       Y -> C (in OTCD; late onset;
FT                                dbSNP:rs72556283).
FT                                {ECO:0000269|PubMed:8956038}.
FT                                /FTId=VAR_004889.
FT   VARIANT     178    179       Missing (in OTCD; neonatal).
FT                                /FTId=VAR_004891.
FT   VARIANT     178    178       T -> M (in OTCD; neonatal;
FT                                dbSNP:rs72556284).
FT                                /FTId=VAR_004890.
FT   VARIANT     180    180       Q -> H (in OTCD; dbSNP:rs72556287).
FT                                {ECO:0000269|PubMed:9452024}.
FT                                /FTId=VAR_004892.
FT   VARIANT     181    181       E -> G (in OTCD; neonatal;
FT                                dbSNP:rs72556290).
FT                                /FTId=VAR_004893.
FT   VARIANT     182    182       H -> L (in OTCD; dbSNP:rs72556291).
FT                                {ECO:0000269|PubMed:8019569}.
FT                                /FTId=VAR_004894.
FT   VARIANT     183    183       Y -> C (in OTCD; dbSNP:rs72556293).
FT                                /FTId=VAR_004895.
FT   VARIANT     183    183       Y -> D (in OTCD; late onset;
FT                                dbSNP:rs72556292).
FT                                {ECO:0000269|PubMed:9143919}.
FT                                /FTId=VAR_004896.
FT   VARIANT     188    188       G -> R (in OTCD; neonatal;
FT                                dbSNP:rs72556294).
FT                                {ECO:0000269|PubMed:8807340}.
FT                                /FTId=VAR_004897.
FT   VARIANT     188    188       G -> V (in OTCD; dbSNP:rs72556295).
FT                                {ECO:0000269|PubMed:10502831}.
FT                                /FTId=VAR_009234.
FT   VARIANT     191    191       L -> F (in OTCD; dbSNP:rs72556296).
FT                                {ECO:0000269|PubMed:11793483}.
FT                                /FTId=VAR_012652.
FT   VARIANT     192    192       S -> R (in OTCD; neonatal;
FT                                dbSNP:rs72556298).
FT                                /FTId=VAR_004898.
FT   VARIANT     195    195       G -> R (in OTCD; no activity;
FT                                dbSNP:rs67294955).
FT                                {ECO:0000269|PubMed:7951259,
FT                                ECO:0000269|PubMed:8112735}.
FT                                /FTId=VAR_004899.
FT   VARIANT     196    196       D -> V (in OTCD; neonatal; 3.7% activity;
FT                                dbSNP:rs72556300).
FT                                {ECO:0000269|PubMed:8112735}.
FT                                /FTId=VAR_004900.
FT   VARIANT     196    196       D -> Y (in OTCD; neonatal;
FT                                dbSNP:rs66642398).
FT                                /FTId=VAR_004901.
FT   VARIANT     197    197       G -> E (in OTCD; dbSNP:rs72556302).
FT                                /FTId=VAR_004902.
FT   VARIANT     197    197       G -> R (in OTCD; dbSNP:rs72556301).
FT                                {ECO:0000269|PubMed:10502831}.
FT                                /FTId=VAR_009235.
FT   VARIANT     198    198       N -> K (in OTCD; dbSNP:rs72558404).
FT                                {ECO:0000269|PubMed:10070627}.
FT                                /FTId=VAR_010606.
FT   VARIANT     201    201       L -> P (in OTCD; neonatal;
FT                                dbSNP:rs72558407).
FT                                {ECO:0000269|PubMed:9452024}.
FT                                /FTId=VAR_004903.
FT   VARIANT     202    202       H -> Y (in OTCD; dbSNP:rs72558408).
FT                                {ECO:0000269|Ref.32}.
FT                                /FTId=VAR_004904.
FT   VARIANT     203    203       S -> C (in OTCD; dbSNP:rs72558410).
FT                                {ECO:0000269|PubMed:8019569}.
FT                                /FTId=VAR_004905.
FT   VARIANT     206    206       M -> I (in OTCD; dbSNP:rs72558413).
FT                                {ECO:0000269|PubMed:11793483}.
FT                                /FTId=VAR_012653.
FT   VARIANT     206    206       M -> R (in OTCD; neonatal;
FT                                dbSNP:rs72558412).
FT                                /FTId=VAR_004906.
FT   VARIANT     207    207       S -> R (in OTCD; neonatal;
FT                                dbSNP:rs72558415).
FT                                {ECO:0000269|PubMed:9452024}.
FT                                /FTId=VAR_004907.
FT   VARIANT     208    208       A -> T (in OTCD; late onset;
FT                                dbSNP:rs72558416).
FT                                /FTId=VAR_004908.
FT   VARIANT     209    209       A -> V (in OTCD; neonatal;
FT                                dbSNP:rs72558417).
FT                                {ECO:0000269|PubMed:10070627,
FT                                ECO:0000269|PubMed:8530002,
FT                                ECO:0000269|PubMed:8807340}.
FT                                /FTId=VAR_004909.
FT   VARIANT     213    213       M -> K (in OTCD; late onset).
FT                                {ECO:0000269|PubMed:9143919}.
FT                                /FTId=VAR_004910.
FT   VARIANT     214    214       H -> Y (in OTCD; neonatal;
FT                                dbSNP:rs72558420).
FT                                {ECO:0000269|PubMed:8830175}.
FT                                /FTId=VAR_010607.
FT   VARIANT     216    216       Q -> E (in OTCD; dbSNP:rs72558423).
FT                                {ECO:0000269|PubMed:2474822}.
FT                                /FTId=VAR_004911.
FT   VARIANT     220    220       P -> A (in OTCD; late onset;
FT                                dbSNP:rs72558425).
FT                                {ECO:0000269|PubMed:8956038}.
FT                                /FTId=VAR_004912.
FT   VARIANT     225    225       P -> L (in OTCD; dbSNP:rs67120076).
FT                                {ECO:0000269|PubMed:1721894}.
FT                                /FTId=VAR_004913.
FT   VARIANT     225    225       P -> R (in OTCD; neonatal;
FT                                dbSNP:rs67120076).
FT                                /FTId=VAR_004914.
FT   VARIANT     225    225       P -> T (in OTCD; late onset;
FT                                dbSNP:rs72558428).
FT                                {ECO:0000269|PubMed:7951259}.
FT                                /FTId=VAR_004915.
FT   VARIANT     242    242       T -> I (in OTCD; late onset;
FT                                dbSNP:rs72558435).
FT                                /FTId=VAR_004916.
FT   VARIANT     244    244       L -> Q (in OTCD; late onset;
FT                                dbSNP:rs72558436).
FT                                {ECO:0000269|PubMed:9452049}.
FT                                /FTId=VAR_004917.
FT   VARIANT     247    247       T -> K (in OTCD; neonatal/late onset;
FT                                dbSNP:rs72558437).
FT                                /FTId=VAR_004918.
FT   VARIANT     255    255       H -> P (in OTCD; dbSNP:rs72558440).
FT                                /FTId=VAR_004919.
FT   VARIANT     262    262       T -> K (in OTCD; mild; dbSNP:rs67333670).
FT                                {ECO:0000269|PubMed:10737985}.
FT                                /FTId=VAR_010608.
FT   VARIANT     263    263       D -> G (in OTCD; dbSNP:rs72558443).
FT                                /FTId=VAR_004920.
FT   VARIANT     263    263       D -> N (in OTCD; dbSNP:rs72558442).
FT                                {ECO:0000269|Ref.32}.
FT                                /FTId=VAR_004921.
FT   VARIANT     264    264       T -> A (in OTCD; late onset; 8.9%
FT                                activity; dbSNP:rs72558444).
FT                                {ECO:0000269|PubMed:10737985,
FT                                ECO:0000269|PubMed:8112735}.
FT                                /FTId=VAR_004922.
FT   VARIANT     264    264       T -> I (in OTCD; late onset;
FT                                dbSNP:rs67156896).
FT                                {ECO:0000269|PubMed:9452024}.
FT                                /FTId=VAR_004923.
FT   VARIANT     265    265       W -> L (in OTCD; mild; dbSNP:rs72558446).
FT                                {ECO:0000269|PubMed:10737985}.
FT                                /FTId=VAR_010609.
FT   VARIANT     267    267       S -> R (in OTCD; dbSNP:rs72558448).
FT                                {ECO:0000269|PubMed:9452024}.
FT                                /FTId=VAR_004924.
FT   VARIANT     268    268       M -> T (in OTCD; late onset;
FT                                dbSNP:rs72558449).
FT                                /FTId=VAR_004925.
FT   VARIANT     269    269       G -> E (in OTCD; neonatal;
FT                                dbSNP:rs72558450).
FT                                {ECO:0000269|PubMed:7474905}.
FT                                /FTId=VAR_004926.
FT   VARIANT     270    270       Q -> R (in about 5% of population;
FT                                dbSNP:rs1800328).
FT                                {ECO:0000269|PubMed:10070627,
FT                                ECO:0000269|PubMed:16959974,
FT                                ECO:0000269|PubMed:6372096}.
FT                                /FTId=VAR_004927.
FT   VARIANT     272    272       Missing (in OTCD; late onset).
FT                                {ECO:0000269|PubMed:8956045}.
FT                                /FTId=VAR_004928.
FT   VARIANT     277    277       R -> Q (in OTCD; late onset;
FT                                dbSNP:rs66724222).
FT                                {ECO:0000269|PubMed:7951259,
FT                                ECO:0000269|PubMed:8081373}.
FT                                /FTId=VAR_004929.
FT   VARIANT     277    277       R -> W (in OTCD; late onset;
FT                                dbSNP:rs72558454).
FT                                {ECO:0000269|PubMed:2347583,
FT                                ECO:0000269|PubMed:9065786}.
FT                                /FTId=VAR_004930.
FT   VARIANT     301    301       L -> F (in OTCD; dbSNP:rs72558462).
FT                                {ECO:0000269|PubMed:11793483}.
FT                                /FTId=VAR_012654.
FT   VARIANT     302    302       H -> L (in OTCD; female; late onset;
FT                                dbSNP:rs67993095).
FT                                {ECO:0000269|PubMed:8807340}.
FT                                /FTId=VAR_004931.
FT   VARIANT     302    302       H -> Q (in OTCD; late onset;
FT                                dbSNP:rs67870244).
FT                                /FTId=VAR_004932.
FT   VARIANT     302    302       H -> Y (in OTCD; neonatal;
FT                                dbSNP:rs72558463).
FT                                {ECO:0000269|PubMed:8956038}.
FT                                /FTId=VAR_004933.
FT   VARIANT     303    303       C -> R (in OTCD; neonatal;
FT                                dbSNP:rs67468335).
FT                                {ECO:0000269|PubMed:9452049}.
FT                                /FTId=VAR_004934.
FT   VARIANT     303    303       C -> Y (in OTCD; dbSNP:rs72558464).
FT                                /FTId=VAR_004935.
FT   VARIANT     304    304       L -> F (in OTCD; dbSNP:rs72558465).
FT                                {ECO:0000269|PubMed:1480464}.
FT                                /FTId=VAR_004936.
FT   VARIANT     305    305       P -> H (in OTCD; dbSNP:rs67501347).
FT                                {ECO:0000269|PubMed:11793483}.
FT                                /FTId=VAR_012655.
FT   VARIANT     309    309       Missing (in OTCD; late onset).
FT                                {ECO:0000269|PubMed:7951259}.
FT                                /FTId=VAR_004937.
FT   VARIANT     320    320       R -> L (in OTCD; dbSNP:rs72558474).
FT                                {ECO:0000269|PubMed:1671317}.
FT                                /FTId=VAR_004938.
FT   VARIANT     326    326       E -> K (in OTCD; dbSNP:rs72558476).
FT                                {ECO:0000269|PubMed:10070627}.
FT                                /FTId=VAR_010610.
FT   VARIANT     330    330       R -> G (in OTCD; dbSNP:rs72558478).
FT                                /FTId=VAR_004939.
FT   VARIANT     333    333       T -> A. {ECO:0000269|PubMed:11793483}.
FT                                /FTId=VAR_012656.
FT   VARIANT     336    336       A -> S (in OTCD; late onset;
FT                                dbSNP:rs72558486).
FT                                /FTId=VAR_004940.
FT   VARIANT     337    337       V -> L (in OTCD; late onset;
FT                                dbSNP:rs72558487).
FT                                /FTId=VAR_004941.
FT   VARIANT     339    339       V -> L (in OTCD; neonatal;
FT                                dbSNP:rs72558488).
FT                                /FTId=VAR_004942.
FT   VARIANT     340    340       S -> P (in OTCD; late onset;
FT                                dbSNP:rs72558489).
FT                                {ECO:0000269|PubMed:9143919}.
FT                                /FTId=VAR_004943.
FT   VARIANT     341    341       L -> P (in OTCD; dbSNP:rs72558490).
FT                                {ECO:0000269|PubMed:11793483}.
FT                                /FTId=VAR_012657.
FT   VARIANT     343    343       T -> K (in OTCD; late onset;
FT                                dbSNP:rs72558491).
FT                                {ECO:0000269|PubMed:8956038}.
FT                                /FTId=VAR_004944.
FT   VARIANT     345    345       Y -> C (in OTCD; neonatal;
FT                                dbSNP:rs72558492).
FT                                /FTId=VAR_004946.
FT   VARIANT     345    345       Y -> D (in OTCD; dbSNP:rs66469337).
FT                                {ECO:0000269|PubMed:1480464}.
FT                                /FTId=VAR_004947.
FT   VARIANT     354    354       F -> C (in OTCD; late onset;
FT                                dbSNP:rs72558495).
FT                                /FTId=VAR_004948.
FT   CONFLICT    193    194       WI -> CF (in Ref. 1; AAA59975).
FT                                {ECO:0000305}.
FT   HELIX        45     47       {ECO:0000244|PDB:1OTH}.
FT   HELIX        50     68       {ECO:0000244|PDB:1OTH}.
FT   TURN         76     79       {ECO:0000244|PDB:1OTH}.
FT   STRAND       81     88       {ECO:0000244|PDB:1OTH}.
FT   HELIX        92    103       {ECO:0000244|PDB:1OTH}.
FT   STRAND      107    112       {ECO:0000244|PDB:1OTH}.
FT   TURN        113    115       {ECO:0000244|PDB:1OTH}.
FT   TURN        119    121       {ECO:0000244|PDB:1OTH}.
FT   HELIX       124    134       {ECO:0000244|PDB:1OTH}.
FT   STRAND      136    141       {ECO:0000244|PDB:1OTH}.
FT   HELIX       145    154       {ECO:0000244|PDB:1OTH}.
FT   STRAND      159    162       {ECO:0000244|PDB:1OTH}.
FT   HELIX       169    183       {ECO:0000244|PDB:1OTH}.
FT   STRAND      190    195       {ECO:0000244|PDB:1OTH}.
FT   HELIX       199    205       {ECO:0000244|PDB:1OTH}.
FT   TURN        206    208       {ECO:0000244|PDB:1OTH}.
FT   HELIX       209    211       {ECO:0000244|PDB:1OTH}.
FT   STRAND      214    218       {ECO:0000244|PDB:1OTH}.
FT   HELIX       227    240       {ECO:0000244|PDB:1OTH}.
FT   STRAND      244    248       {ECO:0000244|PDB:1OTH}.
FT   HELIX       250    254       {ECO:0000244|PDB:1OTH}.
FT   STRAND      258    262       {ECO:0000244|PDB:1OTH}.
FT   HELIX       271    273       {ECO:0000244|PDB:1OTH}.
FT   HELIX       274    280       {ECO:0000244|PDB:1OTH}.
FT   TURN        281    283       {ECO:0000244|PDB:1OTH}.
FT   HELIX       288    292       {ECO:0000244|PDB:1OTH}.
FT   STRAND      299    302       {ECO:0000244|PDB:1OTH}.
FT   TURN        308    310       {ECO:0000244|PDB:1OTH}.
FT   HELIX       313    316       {ECO:0000244|PDB:1OTH}.
FT   HELIX       323    342       {ECO:0000244|PDB:1OTH}.
SQ   SEQUENCE   354 AA;  39935 MW;  AE15B734F6E27A3B CRC64;
     MLFNLRILLN NAAFRNGHNF MVRNFRCGQP LQNKVQLKGR DLLTLKNFTG EEIKYMLWLS
     ADLKFRIKQK GEYLPLLQGK SLGMIFEKRS TRTRLSTETG FALLGGHPCF LTTQDIHLGV
     NESLTDTARV LSSMADAVLA RVYKQSDLDT LAKEASIPII NGLSDLYHPI QILADYLTLQ
     EHYSSLKGLT LSWIGDGNNI LHSIMMSAAK FGMHLQAATP KGYEPDASVT KLAEQYAKEN
     GTKLLLTNDP LEAAHGGNVL ITDTWISMGQ EEEKKKRLQA FQGYQVTMKT AKVAASDWTF
     LHCLPRKPEE VDDEVFYSPR SLVFPEAENR KWTIMAVMVS LLTDYSPQLQ KPKF
//
